|
Dr. William Sheridan joined BioCryst in July 2008. Dr. Sheridan is a seasoned biotechnology professional most recently serving as Vice President of North American Medical Affairs at Amgen Inc. During his 15-year tenure at Amgen Dr. Sheridan organized and led the company's US Medical Affairs function making significant contributions to the successful launch of many compounds including Aranesp® Enbrel® Kineret® Neulasta® and Sensipar®. In addition to his most recent position Dr. Sheridan held titles at the Vice President level at Amgen in International Medical Affairs Global Health Economics and Outcomes Research US Medical Affairs and Product Development. He played an integral role in building Amgen's international medical affairs function and in forming the health economics and outcomes unit. Dr. Sheridan earned his MB BS degree (M.D. equivalent) at the University of Melbourne in Victoria. Dr. Sheridan is a board-certified fellow of the Royal Australasian College of Physicians (FRACP) with a sub-specialty in medical oncology. | 